Eric D. Shaff, CEO and President: Seres Therapeutics MCRB Sell · Filed 24/11/19

Trade details

Type: Insider sale
Amount: $1,352.7
Shares · price: 2,505 sh · $0.54 a share
Held after: 170,389 sh
Stock: Seres Therapeutics MCRB
Person: Eric D. ShaffCEO and President
Trade date: 24/11/18
Filed: 24/11/19
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Seres Therapeutics trades, last 26 weeks

What else happened in Seres Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/19~24/12/18

Eric D. Shaff's recent trades

Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,950
259 sh
$1,950
Filed 05/19
Traded 05/18
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$2,194
259 sh
$2,194
Filed 02/18
Traded 02/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,754
217 sh
$3,754
Filed 25/11/18
Traded 25/11/15
Eric D. ShaffDirector
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$3,613
217 sh
$3,613
Filed 25/08/19
Traded 25/08/18
Eric D. ShaffCEO and President
Sell10b5-1 planSeres Therapeutics
Sell10b5-1 plan
Seres Therapeutics
MCRB
$1,602
220 sh
$1,602
Filed 25/05/19
Traded 25/05/16